Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer

被引：4
|
作者：
Dendl, Katharina [1 ,2 ]
Koerber, Stefan A. [3 ,4 ]
Watabe, Tadashi [5 ]
Haberkorn, Uwe [1 ]
Giesel, Frederik L. [1 ,2 ]
机构：
[1] Univ Hosp Heidelberg, Dept Nucl Med, INF 400, Heidelberg, Germany
[2] Deaprtment Nucl Med, Geb 13-55,Moorenstr 5, D-40225 Dusseldorf, Germany
[3] Krankenhaus Barmherzige Bruder, Dept Radiooncol & Radiat Therapy, Prufeninger Str, D-93049 Regensburg, Germany
[4] Dept Nucl Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan
[5] Dept Nucl Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan
来源：
PET CLINICS | 2023年 / 18卷 / 03期
关键词：
Fibroblast activation protein inhibitor (FAPI; PET; CT; Gynecological malignancies; Breast cancer; FAP; RECURRENCE; EXPRESSION; CARCINOMA; SEPRASE; PET/CT; TARGET; MRI; FDG;
D O I：
10.1016/j.cpet.2023.03.005
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：345 / 351
页数：7
相关论文
共 50 条
  • [21] Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer
    Mathieson, Layla
    O'Connor, Richard A.
    Stewart, Hazel
    Shaw, Paige
    Dhaliwal, Kevin
    Williams, Gareth O. S.
    Megia-Fernandez, Alicia
    Akram, Ahsan R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
    Imlimthan, Surachet
    Moon, Euy Sung
    Rathke, Hendrik
    Afshar-Oromieh, Ali
    Roesch, Frank
    Rominger, Axel
    Gourni, Eleni
    PHARMACEUTICALS, 2021, 14 (10)
  • [23] Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
    Sobhani, Navid
    Ianza, Anna
    D'Angelo, Alberto
    Roviello, Giandomenico
    Giudici, Fabiola
    Bortul, Marina
    Zanconati, Fabrizio
    Bottin, Cristina
    Generali, Daniele
    CELLS, 2018, 7 (07)
  • [24] Current status of breast cancer screening in the world
    Morimoto, Tadaoki
    Nagao, Taeko
    Okazaki, Kenji
    Kira, Misako
    Nakagawa, Yasushi
    Tangoku, Akira
    BREAST CANCER, 2009, 16 (01) : 2 - 9
  • [25] Checkpoint inhibitors in breast cancer - Current status
    Polk, Anne
    Svane, Inge-Marie
    Andersson, Michael
    Nielsen, Dorte
    CANCER TREATMENT REVIEWS, 2018, 63 : 122 - 134
  • [26] Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA
    Backhaus, P.
    Gierse, F.
    Burg, M. C.
    Buether, F.
    Asmus, I
    Dorten, P.
    Cufe, J.
    Roll, W.
    Neri, D.
    Cazzamalli, S.
    Millul, J.
    Mock, J.
    Galbiati, A.
    Zana, A.
    Schaefers, K. P.
    Hermann, S.
    Weckesser, M.
    Tio, J.
    Wagner, S.
    Breyholz, H-J
    Schaefers, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (06) : 1822 - 1832
  • [27] Fibroblast-activation protein: valuable marker of cutaneous epithelial malignancy
    El Khoury, Jinane
    Kurban, Mazen
    Kibbi, Abdul-Ghani
    Abbas, Ossama
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2014, 306 (04) : 359 - 365
  • [28] Effects of the fibroblast activation protein on the invasion and migration of gastric cancer
    Wang, Rui-Fen
    Zhang, Li-Hong
    Shan, Li-Hui
    Sun, Wen-Guang
    Chai, Cui-Cui
    Wu, Hong-Mei
    Ibla, Juan C.
    Wang, Li-Feng
    Liu, Jia-Ren
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (03) : 350 - 356
  • [29] Activation of major vault protein by TGF-beta is associated with advanced malignancy and poor prognosis in breast cancer
    Zhang, Jinghua
    Gao, Jinghua
    Liu, Zhibao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (06): : 6179 - 6186
  • [30] Clinical Findings on Fibroblast Activation Protein in Patients with Gastric Cancer
    Fukumoto, Youji
    Yamada, Yoshinori
    Fukuda, Kenji
    Saito, Hiroaki
    Tatebe, Shigeru
    Tsujitani, Shunichi
    Ikeguchi, Masahide
    YONAGO ACTA MEDICA, 2009, 52 (01) : 21 - 25
12345